N-benzyl-3,4-dihyroxypyridine-2-carboxamide and N-benzyl2,3-dihydroxypyridine-4-carboxamide compounds useful as HIV integrase inhibitors

Details for Australian Patent Application No. 2005211349 (hide)

Owner Merck & Co., Inc. Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.p.A.

Inventors Kuo, Michelle Sparks; Vacca, Joseph P.; Morrissette, Matthew M.; Jones, Philip; Williams, Peter D.

Agent Spruson & Ferguson

Pub. Number AU-A-2005211349

PCT Pub. Number WO2005/074513

Priority 60/540,538 30.01.04 US

Filing date 26 January 2005

Wipo publication date 18 August 2005

International Classifications

A61K 31/44 (2006.01) - Non-condensed pyridines

C07D 211/74 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

Event Publications

24 August 2006 PCT application entered the National Phase

  PCT publication WO2005/074513 Priority application(s): WO2005/074513

19 August 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005211351-Aerosol spray resistant to discoloration

2005211345-Nonabrasive sensory exfoliating system